Diffusion Pharmaceuticals
DFFN
#10331
Rank
C$12.27 M
Marketcap
C$6.02
Share price
10.28%
Change (1 day)
-36.79%
Change (1 year)

Earnings for Diffusion Pharmaceuticals (DFFN)

Earnings in 2023 (TTM): -C$17.72 Million

According to Diffusion Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$21.33 Million, an increase over its 2021 earnings that were of -C$33.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Diffusion Pharmaceuticals from 1999 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$17.72 Million-16.91%
2022 -C$21.33 Million-36.46%
2021 -C$33.57 Million54.72%
2020 -C$21.7 Million38.32%
2019 -C$15.69 Million-39.03%
2018 -C$25.73 Million677.09%
2017 -C$3.32 Million-86.85%
2016 -C$25.17 Million-22.75%
2015 -C$32.59 Million38.74%
2014 -C$23.49 Million598.54%
2013 -C$3.37 Million-57.56%
2012 -C$7.93 Million-62.43%
2011 -C$21.09 Million58.75%
2010 -C$13.29 Million238.41%
2009 -C$3.93 Million189.55%
2008 -C$1.36 Million1576.75%
2007 -C$0.09 Million-35.01%
2006 -C$0.13 Million
1999 -C$10.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 1,031.69%๐Ÿ‡บ๐Ÿ‡ธ USA